Login

Mike McCormick, CEO, Osprey Medical Inc 00:00:00

Share On Facebook Share On Twitter

Osprey Medical Inc

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Understanding the Economic Landscape: Perspectives on Financial Health and Long-Term Challenges | Thasunda Brown Duckett, CEO , TIAA.
00:10:00
Senior Advisor on Retirement Strategies at BlackRock
00:00:00
Global Health Leadership in the Private Sector - a conversation with Medistim CEO Kari E. Krogstad - Kari E. Krogstad, CEO, Medistim
00:10:00
Employee 1st Impact: Insights from H&E Equipment Services CEO | Bradley W. Barber - Chief Executive Officer and Director of H&E Equipment Services, Inc.
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
focusing on automation of the largest sectors of the Real Economy|Adeyemi Ajao,Managing Partner,Base10 Partners
00:10:00
Pioneering Cloud Tech: Gordon McArthur on Catalyzing Adoption in Financial Services and Future Innovations|CEO, Beeks Financial Cloud Group PLC
00:10:00
Mike Salvino, President and CEO of DXC, shares leadership advice with Marietta College's graduating class.|Raul Fernandez is president and chief executive officer of DXC Technology
00:10:00
John Inch of Gordon Haskett provides in-depth insights on market trends and investment strategies in this full interview.
00:10:00
"Exploring Ethical Challenges and Global Investment Strategies: A Conversation with Alex Chitea, Managing Partner at Funston Capital"
00:10:00
Playbook to Evolving Your Product Genetics|Miles Grimshaw,General Partner,Benchmark
00:10:00
Insights on Electricity Prices, Property Segments, and the Future of Offices from Castellum's CEO | Rutger Arnhult, CEO,Castellum AI

© 2026 Nehu